Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation.

The extracellular signal-regulated kinases (ERKs) are required for thrombopoietin (TPO) functions on hematopoietic cells, but the ERKs targets involved remain unknown. Here we show that the regulation of the immediate early gene X-1 (IEX-1), identified as an ERK substrate in response to TPO, was mediated by an ERK-dependent phosphorylation of AML1. The addition of TPO to UT7-Mpl cells and primary megakaryocytes induced gene expression of IEX-1. Neither erythropoietin (EPO) nor granulocyte macrophage-colony stimulating factor (GM-CSF) was able to activate IEX-1 gene expression in UT7-Mpl cells. The induced expression was mediated by a transcriptional activation of the IEX-1 promoter and required an AML1-binding site located at -1068. The direct involvement of AML1 in the regulation of IEX-1 gene expression was shown by both the use of AML1 mutants and by shRNA experiments targeting endogenous AML1. Finally, the ability of TPO to induce the IEX-1 gene expression was inhibited by U0126, a specific inhibitor of the ERKs activator MEK and AML1 transcriptional activity was shown to be modulated by TPO through ERK-dependent phosphorylation. Taken together, these data suggest that AML1 plays a role in modulating the IEX-1 expression and that the ERK-dependent AML1 phosphorylation regulates the TPO-mediated activation of IEX-1.

[1]  C. Pirola,et al.  Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. , 2005, Blood.

[2]  J. Biggs,et al.  Phorbol Ester Treatment of K562 Cells Regulates the Transcriptional Activity of AML1c through Phosphorylation* , 2004, Journal of Biological Chemistry.

[3]  J. Downing,et al.  Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors. , 2004, Blood.

[4]  N. Ahn,et al.  Extracellular Signal-Regulated Kinase Induces the Megakaryocyte GPIIb/CD41 Gene through MafB/Kreisler , 2004, Molecular and Cellular Biology.

[5]  J. Downing,et al.  Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression. , 2004, Blood.

[6]  T. Kyo,et al.  High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. , 2004, Blood.

[7]  S. Ogawa,et al.  AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis , 2004, Nature Medicine.

[8]  T. Noda,et al.  The Corepressor mSin3A Regulates Phosphorylation-Induced Activation, Intranuclear Location, and Stability of AML1 , 2004, Molecular and Cellular Biology.

[9]  M. Kurokawa,et al.  Role of AML1/Runx1 in the pathogenesis of hematological malignancies , 2003, Cancer science.

[10]  Kamaleldin E Elagib,et al.  RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. , 2003, Blood.

[11]  A. Nordheim,et al.  AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells. , 2003, Blood.

[12]  F. Porteu,et al.  IEX‐1: a new ERK substrate involved in both ERK survival activity and ERK activation , 2002, The EMBO journal.

[13]  N. Fox,et al.  Thrombopoietin expands hematopoietic stem cells after transplantation. , 2002, The Journal of clinical investigation.

[14]  I. Matsumura,et al.  Molecular Control of Megakaryopoiesis and Thrombopoiesis , 2002, International journal of hematology.

[15]  K. Kaushansky,et al.  The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production , 2002, Oncogene.

[16]  R. Kumar,et al.  Divergent Regulation of the Growth-promoting GeneIEX-1 by the p53 Tumor Suppressor and Sp1* , 2002, The Journal of Biological Chemistry.

[17]  Hermona Soreq,et al.  Runx1/AML1 in leukemia: disrupted association with diverse protein partners. , 2002, Leukemia research.

[18]  Mei X. Wu,et al.  Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Kumar,et al.  IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes , 2001, Oncogene.

[20]  Y. Miyakawa,et al.  The Roles of Phosphatidylinositol 3-Kinase and Protein Kinase Cζ for Thrombopoietin-induced Mitogen-activated Protein Kinase Activation in Primary Murine Megakaryocytes* , 2001, The Journal of Biological Chemistry.

[21]  F. Zintl,et al.  Evidence for a novel thrombopoietin signalling event: activation of protein kinase A in human megakaryoblastic CMK cells. , 2001, Cytokine.

[22]  I. Dusanter-Fourt,et al.  Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo) , 2001, Oncogene.

[23]  G. Krupp,et al.  Functional disruption of IEX‐1 expression by concatemeric hammerhead ribozymes alters growth properties of 293 cells , 2001, FEBS letters.

[24]  J. de Gunzburg,et al.  Thrombopoietin-Mediated Sustained Activation of Extracellular Signal-Regulated Kinase in UT7-Mpl Cells Requires Both Ras–Raf-1- and Rap1–B-Raf-Dependent Pathways , 2001, Molecular and Cellular Biology.

[25]  P. Charneau,et al.  Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  Y. Miyakawa,et al.  Thrombopoietin Induces Phosphoinositol 3-Kinase Activation through SHP2, Gab, and Insulin Receptor Substrate Proteins in BAF3 Cells and Primary Murine Megakaryocytes* , 2001, The Journal of Biological Chemistry.

[27]  M. Kurokawa,et al.  Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis. , 2000, Blood.

[28]  E. Macintyre,et al.  High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21 , 2000 .

[29]  R. Yeager,et al.  Pharmacokinetics and Hematological Effects of the PEGylated Thrombopoietin Peptide Mimetic GW395058 in Rats and Monkeys After Intravenous or Subcutaneous Administration , 1999, Stem cells.

[30]  John M. Maris,et al.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.

[31]  F. Porteu,et al.  Megakaryocyte Growth and Development Factor-Induced Proliferation and Differentiation Are Regulated by the Mitogen-Activated Protein Kinase Pathway in Primitive Cord Blood Hematopoietic Progenitors , 1999 .

[32]  K. Kaushansky,et al.  Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. , 1999, Blood.

[33]  K. Kaushansky,et al.  Thrombopoietin Signal Transduction Requires Functional JAK2, Not TYK2* , 1999, The Journal of Biological Chemistry.

[34]  R. Kumar,et al.  Regulation of a novel immediate early response gene, IEX-1, in keratinocytes by 1alpha,25-dihydroxyvitamin D3. , 1998, Biochemical and biophysical research communications.

[35]  T. Hirano,et al.  Involvement of Prolonged Ras Activation in Thrombopoietin-Induced Megakaryocytic Differentiation of a Human Factor-Dependent Hematopoietic Cell Line , 1998, Molecular and Cellular Biology.

[36]  F.J. Sauvage,et al.  Role of c-mpl in early hematopoiesis. , 1998, Blood.

[37]  W. Deppert,et al.  The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene , 1998, Oncogene.

[38]  A T Look,et al.  Oncogenic transcription factors in the human acute leukemias. , 1997, Science.

[39]  T. Vik,et al.  Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells. , 1997, Blood.

[40]  P. Gadue,et al.  Activation of the Megakaryocyte-specific Gene Platelet Basic Protein (PBP) by the Ets Family Factor PU.1* , 1997, The Journal of Biological Chemistry.

[41]  S. Goueli,et al.  Sustained Activation of the Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway Is Required for Megakaryocytic Differentiation of K562 Cells* , 1997, The Journal of Biological Chemistry.

[42]  I. Dusanter-Fourt,et al.  Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway , 1997, Molecular and cellular biology.

[43]  D. Baccanari,et al.  Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. , 1997, Science.

[44]  N. Ahn,et al.  Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase , 1997, Molecular and cellular biology.

[45]  K. Tanaka,et al.  The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability , 1996, Molecular and cellular biology.

[46]  U. Fölsch,et al.  PRG1: a novel early-response gene transcriptionally induced by pituitary adenylate cyclase activating polypeptide in a pancreatic carcinoma cell line. , 1996, Cancer research.

[47]  I. Dusanter-Fourt,et al.  Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin , 1996, Molecular and cellular biology.

[48]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[49]  D. Levy,et al.  Thrombopoietin activates a STAT5‐like factor in hematopoietic cells. , 1995, The EMBO journal.

[50]  Gregory Riely,et al.  Isolation and characterization of a TATA-less promoter for the human beta 3 integrin gene. , 1994, Blood.

[51]  M. Wu Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis , 2004, Apoptosis.

[52]  H Phillip Koeffler,et al.  Myelodysplastic Bone Marrow Cells from Normal and + Characterization of Gene Expression of Cd34 , 2002 .

[53]  E. Macintyre,et al.  High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. , 2000, Blood.

[54]  F. Porteu,et al.  Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. , 1999, Blood.

[55]  M. Zutter,et al.  Regulation of alpha 2 integrin gene expression in cells with megakaryocytic features: a common theme of three necessary elements. , 1995, Blood.